Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Japan Likely the Only Negative Growth Pharma Market in 2018-2022: IQVIA
March 16, 2018
- Rohto Wins Japan Exclusive Rights to JT’s JAK Inhibitor in Ophthalmology Field
March 16, 2018
- Ono Exercises Option to Ink New Autoimmune Disease Deal with Merus
March 15, 2018
- Shionogi’s Single-Dose Flu Med Xofluza Hits Japan Shelves
March 15, 2018
- Kaketsuken, Meiji-Kumamoto JV, Ink Deal on Share Transfer of New Company, with Completion Date Set on July 2
March 15, 2018
- Re-Pricing Rule for Indication Expansions Mars I/O Development: MSD Japan Chief
March 14, 2018
- Gilead Japan Rolling Up Its Sleeves for Foray into Oncology/Inflammation Market
March 14, 2018
- Toyama Chemical Begins Patient Enrollment in Japan PIII Study of Avigan for SFTS
March 13, 2018
- EA Pharma’s Livact Now Available in Thailand
March 12, 2018
- Solifenacin Oral Suspension Approved in Europe for Pediatric NDO: Astellas
March 12, 2018
- Costa Saroukos Tapped as Takeda’s Global CFO
March 9, 2018
- Hiroo Ito Named New President of Actelion Pharmaceuticals Japan
March 9, 2018
- Daiichi Sankyo’s ADC DS-8201 Enters Global PII Study for Colorectal Cancer
March 9, 2018
- Aducanumab Trial Tweak Has No Impact on Probability of Success: Eisai CEO
March 9, 2018
- Eisai Bags Up-to-US$5.76 Billion Lenvima Alliance with Merck
March 9, 2018
- Foreign Drug Makers Increased Market Share to Over 60% among Top 20 Makers in 2017
March 9, 2018
- Torii’s Futhan to Get 43.4% Price Cut in April, Urinorm 24.6%: Top 5 Product Survey
March 8, 2018
- Insomnia Drug Lemborexant Hits PIII Goals in Sleep Disorders: Eisai
March 8, 2018
- US FDA Approves Latuda for Pediatric Use in Bipolar I Depression: Sumitomo Dainippon
March 8, 2018
- Yoshikazu Aoki Named as New Asahi Kasei Pharma President
March 8, 2018
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…